The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Moschos, Andreas
    Pharmacist born in August 1959
    Individual (3 offsprings)
    Officer
    2015-02-02 ~ now
    OF - director → CIF 0
    Mr Andreas Moschos
    Born in August 1959
    Individual (3 offsprings)
    Person with significant control
    2016-04-07 ~ now
    PE - Has significant influence or controlCIF 0
  • 2
    Sismani, Olympia
    Company Director born in January 1965
    Individual (2 offsprings)
    Officer
    2015-05-14 ~ now
    OF - director → CIF 0
    Olympia Sismani
    Born in January 1965
    Individual (2 offsprings)
    Person with significant control
    2016-04-07 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 3
    Harvey, Terry David
    Accountant born in October 1964
    Individual (12 offsprings)
    Officer
    2015-05-14 ~ now
    OF - director → CIF 0
Ceased 1
  • Lonergan, Denis Cornel
    Accountant born in January 1964
    Individual (38 offsprings)
    Officer
    2015-02-02 ~ 2015-05-14
    OF - director → CIF 0
parent relation
Company in focus

NEXT CLINICAL RESEARCH ORGANISATION LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Fixed Assets
25,701 GBP2023-12-31
25,701 GBP2022-12-31
Current Assets
487,345 GBP2023-12-31
526,124 GBP2022-12-31
Creditors
Current
-420,578 GBP2023-12-31
-379,117 GBP2022-12-31
Net Current Assets/Liabilities
103,717 GBP2023-12-31
162,936 GBP2022-12-31
Total Assets Less Current Liabilities
129,418 GBP2023-12-31
188,637 GBP2022-12-31
Creditors
Non-current
-67,339 GBP2023-12-31
-163,167 GBP2022-12-31
Net Assets/Liabilities
62,079 GBP2023-12-31
25,470 GBP2022-12-31
Equity
62,079 GBP2023-12-31
25,470 GBP2022-12-31
Average Number of Employees
22023-01-01 ~ 2023-12-31

  • NEXT CLINICAL RESEARCH ORGANISATION LIMITED
    Info
    Registered number 09418105
    47 The Ridgeway Friern Barnet, London N11 3LG
    Private Limited Company incorporated on 2015-02-02 (10 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2025-03-09
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.